Combination of bevacizumab and 2-weekly pegylated liposomal doxorubicin as first-line therapy for locally recurrent or metastatic breast cancer. A multicenter, single-arm phase II trial (SAKK 24/06)Christoph Rochlitz, Khalil Zaman, Jens Huober et al.|Annals of Oncology|2010Cited by 26
Capecitabine and Vinorelbine as First-Line Treatment in Elderly Patients (≥65 Years) with Metastatic Breast CancerDagmar Hess, Karin Ribi, Dieter Köberle et al.|Oncology|2007Cited by 24